最新消息
-
Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy
2024-10-02 Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy Minaris Regenerative Medicine, LLC (Minaris) and TFBS Bioscience Inc. (TFBS) are pleased to announce a strategic partnership in cell and gene therapy (CGT) mainly in North America. This collaboration is designed to enhance their capabilities to drive industry innovation by providing the one-stop-shop solutions. Learn more -
President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA
2024-05-08 President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA Learn more -
Mie University, Japan, BioComo Inc., Japan, and TFBS Bioscience Inc., Taiwan collaborate to develop nasal spray vaccine against respiratory syncytial virus.
2024-04-25 Mie University, Japan, BioComo Inc., Japan, and TFBS Bioscience Inc., Taiwan collaborate to develop nasal spray vaccine against respiratory syncytial virus. Mie University, Japan, BioComo Inc., Japan, and TFBS Bioscience Inc., Taiwan collaborate to develop nasal spray vaccine against respiratory syncytial virus. Learn more